ThyCa News

ThyCa To Award New Research Grants in 2011

11/2010

Proposals Due by January 31, 2011; Grants Open to Researchers Worldwide

In 2011, for the ninth year in a row, ThyCa: Thyroid Cancer Survivors' Association, Inc. will award new grants for thyroid cancer research.

ThyCa will award two new grants in 2011. Each grant will be for 2 years. One grant will support research on follicular-cell-derived thyroid cancer, including papillary, follicular, anaplastic, and variants. The other grant will support research in medullary thyroid cancer.

The ThyCa Research grants are open to all researchers and institutions worldwide.

An independent expert panel of the American Thyroid Association (ATA) will select the grant recipients. ATA is the professional association of clinicians and researchers specializing in thyroid diseases.

The Call for Proposals and eligibility requirements will be available on the ATA web site (www.thyroid.org). The deadline for submission of a proposal summary to the ATA is January 31, 2011. The ATA Research Committee will rank proposals according to their scientific merit. ATA will notify the authors of selected proposals by early March and will invite them to submit complete grant applications.

The ThyCa grants, begun in 2003, are the first-ever thyroid cancer research grants to be funded entirely by thyroid cancer patients, caregivers, and friends.

ThyCa has awarded its grants to researchers at the following institutions:

  • Cochin Institut, Paris, France
  • Harvard Medical School, Boston, Massachusetts
  • Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Ohio State University, Columbus, Ohio and Medical University of Gdansk, Poland
  • Memorial Sloan-Kettering Cancer Center, New York, New York
  • Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois
  • University Hospital Basel, Basel, Switzerland
  • University Hospital Duesseldorf, Duesseldorf, Germany
  • University of California Los Angeles (UCLA)/Veterans Affairs West Los Angeles Health Care System, Los Angeles, California
  • University of Illinois at Chicago
  • University of Texas M.D. Anderson Cancer Center, Houston, Texas

ThyCa has two Research Funds. One fund supports research of follicular-cell-derived thyroid cancer, including papillary, follicular, anaplastic, and variants. The other research fund supports research of medullary thyroid cancer.

To find out more about the ThyCa Research Funds and annual Rally for Research, visit http://www.thyca.org/researchfund.htm.

ThyCa invites everyone to join us in our quest to find a cure for all thyroid cancer.


News Archive